Evidence map›Paper›PMID 41091797›Full record

ArticlePLoS neglected tropical diseases2025

Community perceptions and practices on hepatic veno-occlusive disease in Tigray, Ethiopia: An explorative study challenging the attribution to Ageratum conyzoides.

Mekonnen Haileselassie, Yimer Mulugeta Agga, Ataklti Gebretsadik, Ziada Abdelhadi Abdelwahab, Fisseha Ashebir, Mulugeta Woldu Abrha, Brhane Ayele, Hailay Gebretnsae, Hagos Degefa Hidru, Hayelom Kahsay and 15 more

Abstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Mekonnen HaileselassieTigray Health Research Institute, Mekelle, Tigray, Ethiopia.ORCID 0000-0003-2107-3965
Yimer Mulugeta AggaEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Ataklti GebretsadikTigray Health Research Institute, Mekelle, Tigray, Ethiopia.
Ziada Abdelhadi AbdelwahabMekelle University, College of Business and Economics, Mekelle, Tigray, Ethiopia.
Fisseha AshebirTigray Health Research Institute, Mekelle, Tigray, Ethiopia.
Mulugeta Woldu AbrhaTigray Health Research Institute, Mekelle, Tigray, Ethiopia.
Brhane AyeleTigray Health Research Institute, Mekelle, Tigray, Ethiopia.
Hailay GebretnsaeTigray Health Research Institute, Mekelle, Tigray, Ethiopia.
Hagos Degefa HidruTigray Health Research Institute, Mekelle, Tigray, Ethiopia.
Hayelom KahsayTigray Health Research Institute, Mekelle, Tigray, Ethiopia.
Tsegay HadguTigray Health Research Institute, Mekelle, Tigray, Ethiopia.
Yemane Berhane TesfauAdigrat University, College of Health Science, Adigrat, Tigray, Ethiopia.
Abreha Tesfaye GenzebuMekelle University, College of Veterinary Medicine, Mekelle, Tigray, Ethiopia.
Feyisa RegessaEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Geremew TasewEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Getachew TolleraEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Mesay HailuEthiopian Public Health Institute, Addis Ababa, Ethiopia.
Abiy Girmay HaddisWorld Health Organization (WHO), Addis Ababa, Ethiopia.
Senait Tekeste FekaduWorld Health Organization (WHO), Addis Ababa, Ethiopia.
Patrick Okumu AbokWorld Health Organization (WHO), Addis Ababa, Ethiopia.
Samuel AregayWorld Health Organization (WHO), Addis Ababa, Ethiopia.
Mebrahtu HafteTigray Regional Health Bureau, Mekelle, Tigray, Ethiopia.
Amanuel HaileTigray Regional Health Bureau, Mekelle, Tigray, Ethiopia.
Mussie AlemayehuMekelle University, College of Health Sciences, School of Public Health, Mekelle, Tigray, Ethiopia.
Afework MulugetaMekelle University, College of Health Sciences, School of Public Health, Mekelle, Tigray, Ethiopia.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundHepatic veno-occlusive disease (HVOD) is a rare but severe condition characterized by the blockage of microscopic veins in the liver due to endothelial damage, leading to sub-endothelial thickening, edema, and fibrosis. Globally the cause of HVOD is primarily associated with pyrrolizidine alkaloid (PA) ingestion, radiation therapy, and post-transplant reactions. Similarly, in the Tigray region of Ethiopia, the disease's outbreak has been linked with contaminated harvests containing PA-producing seed called "Ageratum conyzoides". However, the perception and current experience of community members and healthcare providers on the cause and prevention strategies of the disease are not explored.

objectiveTo explore the perceptions and practices of community members and healthcare providers on HVOD in Tigray, Ethiopia.

methodsThis qualitative study was conducted in the Tigray Region of Northern Ethiopia from January to February 2025. It employed a community and facility-based approach using in-depth interviews (IDIs), focus group discussions (FGDs), and key informant interviews (KIIs) to explore perceptions and current experiences on the causes and practice of preventive measures of HVOD. We selected five districts with high HVOD burdens. We included religious leaders and HVOD victims from the community members and healthcare leaders and professionals from the health facilities. A total of three FGDs, sixteen IDIs, and seven KIIs were conducted and data was analyzed thematically using Atlas.ti software.

resultsThe community's understanding of HVOD is complex, recognizing it as a severe chronic disease but with uncertainty about its transmission and prevention. Our study identified three key themes: variability in knowledge among community members and healthcare providers regarding HVOD's causes, prevention, and treatment, alongside a notable lack of coordinated leadership and support from healthcare providers, political leaders, and other stakeholders. Participants expressed frustration over the absence of structured interventions for awareness, prevention, and treatment. Additional barriers included skepticism about Ageratum conyzoides as the cause, social stigma, traditional beliefs, political instability, healthcare system weaknesses, and economic challenges. Acceptance of scientific interventions was uneven, shaped by varying levels of trust and resistance. Participants emphasized the need for targeted healthcare provider training, stronger community engagement in awareness and planning, and formal integration of HVOD into national health programs to improve resource allocation and coordination. These findings highlight the complex challenges and inform strategies for more effective HVOD control.

conclusionsHepatic veno-occlusive disease (HVOD) is a significant public health issue in Ethiopia, which is exacerbated by misconceptions and systemic healthcare challenges. To address this, strengthening healthcare systems and community engagement through awareness campaigns are crucial. Integrating HVOD into the national public health emergency management programs with multi-sectoral collaboration could be essential for its effective management.

Indexed as

AgeratumHealth Knowledge, Attitudes, PracticeHepatic Veno-Occlusive DiseaseAdultEthiopiaFemaleHealth PersonnelHumansMaleMiddle AgedPyrrolizidine AlkaloidsYoung AdultPyrrolizidine Alkaloids

Identifiers

PMID41091797
PMCPMC12543276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.